Shi Hua Tan

Shi Hua Tan

Auto-generated profile, based on publicly available information

Shi Hua Tan

A*STAR Skin Research Labs, Agency for Science, Technology and Research (A*STAR), Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2018 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
STShi Hua Tan
Shi Hua Tan
Lei YeLei Ye
Lei Ye

7 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
STShihua Tan
Shihua Tan
ZTZhonghao Tao
Zhonghao Tao
SLSzejie Loo
Szejie Loo
LSLiping Su
Liping Su
XCXin Chen
Xin Chen
Lei YeLei Ye
Lei Ye
Non-viral transfection of mammalian cardiomyocytes (CMs) is challenging. The current study aims to characterize and determine the non-viral vector based gene transfection efficiency with human induced pluripotent stem cells (hiPSCs) derived cardiomyocytes (hiPSC-CMs). hiPSC-CMs differentiated from PCBC hiPSCs were used as a cell model to be transfected with plasmids carrying green fluorescence protein (pGFP) using polyethylenimine (PEI), including Transporter 5 Transfection Reagent (TR5) and PEI25, and liposome, including lipofectamine-2000 (Lipo2K), lipofectamine-3000 (Lipo3K), and Lipofectamine STEM (LipoSTEM). The gene transfection efficiency and cell viability were quantified by flow cytometry. We found that the highest gene transfection efficiency in hiPSC-CMs on day 14 of contraction can be achieved by LipoSTEM which was about 32.5 ± 6.7%. However, it also cuased poor cell viability (60.1 ± 4.5%). Furthermore, a prolonged culture of (transfection on day 23 of contraction) hiPSC-CMs not only improved gene transfection (54.5 ± 8.9%), but also enhanced cell viability (74 ± 4.9%) by LipoSTEM. Based on this optimized gene transfection condition, the highest gene transfection efficiency was 55.6 ± 7.8% or 34.1 ± 4%, respectively, for P1C1 or DP3 hiPSC line that was derived from healthy donor (P1C1) or patient with diabetes (DP3). The cell viability was 80.8 ± 5.2% or 92.9 ± 2.24%, respectively, for P1C1 or DP3. LipoSTEM is a better non-viral vector for gene transfection of hiPSC-CMs. The highest pGFP gene transfection efficiency can reach >50% for normal hiPSC-CMs or >30% for diabetic hiPSC-CMs.

6 August 2025 in Acta Biomaterialia
Verified
Journal Article
Open access
PYPengfei Yan
Pengfei Yan
HZHui Zheng
Hui Zheng
PLPeng Liu
Peng Liu
CYChang Yan
Chang Yan
MZMengqi Zhao
Mengqi Zhao
Swee Hin TeohSwee Hin Teoh
Swee Hin Teoh
Current wound therapies struggle to dynamically regulate immune responses and angiogenesis, often resulting in impaired healing, scarring, and poor tissue regeneration. The development of smart hydrogel scaffolds offers an opportunity to precisely modulate the wound healing process. Here, we present a pioneering wireless immunomodulatory strategy by integrating amino-modified barium titanate (BTN) nanoparticles with a natural collagen matrix, using oxidized gellan gum (OG) as a crosslinker, to fabricate a tilapia collagen (Col)-based biomimetic piezoelectric hydrogel scaffold (Col/OG/BTN). The hydrogel scaffold exhibits skin-like mechanical properties, controlled biodegradability, and ultrasound (US)-activated piezoelectricity, while providing a three-dimensional porous microenvironment for cell migration and signaling. Under US, the hydrogel scaffold reprograms pro-inflammatory M1 macrophages toward pro-healing M2 macrophages by modulating the phosphoinositide 3-kinase (PI3K) /protein kinase B (Akt) and tumor necrosis factor (TNF) signaling pathways, as revealed by transcriptomics. This immunoregulation synergizes with endothelial cell crosstalk to amplify pro-angiogenic factor secretion. Importantly, in vivo application of the Col/OG/BTN hydrogel scaffold significantly reduces inflammation, enhances angiogenesis, promotes collagen deposition, and stimulates hair follicle regeneration, ultimately achieving high-quality wound healing with functional restoration. In conclusion, this study demonstrates a spatiotemporally controllable approach to modulate the immune microenvironment of inflammatory wounds while promoting vascular regeneration, offering a clinically translatable strategy for regenerative medicine. STATEMENT OF SIGNIFICANCE: Current wound therapies face challenges in dynamically regulating immune responses and angiogenesis. We developed a tilapia collagen-based piezoelectric hydrogel scaffold integrated with oxidized gellan gum and amino-modified barium titanate nanoparticles (Col/OG/BTN hydrogel scaffold). This ultrasound-activated system uniquely reprograms pro-inflammatory macrophages to pro-healing phenotypes via PI3K/Akt and TNF pathways, synergistically enhancing angiogenesis and hair follicle regeneration. The scaffold eliminates implanted electrodes, offering wireless immunomodulation and vascular restoration, enabling high-quality wound healing with functional skin appendage recovery. This work provides a clinically translatable strategy for inflammatory wound repair through bioelectrical signaling.

15 October 2018 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
ZTZhonghao Tao
Zhonghao Tao
STShihua Tan
Shihua Tan
WCWen Chen
Wen Chen
XCXin Chen
Xin Chen